1. Academic Validation
  2. Anti-chlamydial activities of cell-permeable hydrophobic dipeptide-containing derivatives

Anti-chlamydial activities of cell-permeable hydrophobic dipeptide-containing derivatives

  • J Infect Chemother. 2019 Dec;25(12):987-994. doi: 10.1016/j.jiac.2019.05.024.
Ryota Itoh 1 Toshinori Soejima 2 Kenji Hiromatsu 2
Affiliations

Affiliations

  • 1 Department of Microbiology & Immunology, Faculty of Medicine, Fukuoka University, Fukuoka, 814-0180, Japan. Electronic address: ryito@fukuoka-u.ac.jp.
  • 2 Department of Microbiology & Immunology, Faculty of Medicine, Fukuoka University, Fukuoka, 814-0180, Japan.
Abstract

The obligate intracellular bacteria chlamydia is major human pathogen that causes millions of trachoma, sexually transmitted infections and pneumonia worldwide. We serendipitously found that both calpain inhibitors z-Val-Phe-CHO and z-Leu-Nle-CHO showed marked inhibitory activity against chlamydial growth in human epithelial HeLa cells, whereas other calpain inhibitors not. These peptidomimetic inhibitors consist of N-benzyloxycarbonyl group and hydrophobic dipeptide derivatives. Both compounds strongly restrict the chlamydial growth even addition at the 12 h post Infection. Notably, inhibitors-mediated growth inhibition of chlamydia was independent on host calpain activity. Electron microscopic analysis revealed that z-Val-Phe-CHO inhibited chlamydial growth by arresting Bacterial cell division and RB-EB re-transition, but not by changing into persistent state. We searched and found that z-Leu-Leu-CHO and z-Phe-Ala-FMK also inhibited chlamydial growth. Neither biotin-hydrophobic dipeptide nor morpholinoureidyl-hydrophobic dipeptide shows inhibitory effects on chlamydial intracellular growth. Our results suggested the possibility of some chemical derivatives based on z-hydrophobic dipeptide group for future therapeutic usage to the chlamydial infectious disease.

Keywords

Antimicrobial agent; Chlamydia spp.; Peptidomimetic compound; Protease inhibitor.

Figures
Products